Spinal Elements received FDA clearance for claims related to its Ti-Bond titanium surface coating technology.
The company's portfolio includes several PEEK interbody fusion products featuring Ti-Bond, including the recently introduced Lucent XP height- and lordosis-expandable interbody device.
"Spinal Elements has had a long, successful experience with the clinical application of Ti-Bond technology in the spine," said Jason Blain, president and CEO of Spinal Elements. "This FDA clearance represents an important scientific element of the overall Ti-Bond story — one that will expand even more as the platform continues to flourish and we provide an increasing number of technology-based solutions to improve patient outcomes."